Skip Nav Destination
Enhancing PD-L1 Degradation by ITCH during MAPK Inhibitor Therapy Suppresses Acquired Resistance
Cancer Discov (2022) 12 (8): 1942–1959.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Kun Pang
- Zhen-Duo Shi
- Liu-Ya Wei
- Yang Dong
- Yu-Yang Ma
- Wei Wang
- Guang-Yue Wang
- Ming-Yang Cao
- Jia-Jun Dong
- Yu-Ang Chen
- Peng Zhang
- Lin Hao
- Hao Xu
- Deng Pan
- Zhe-Sheng Chen
- Cong-Hui Han
Drug Resistance Updates (2023) 66: 100907.
Enhancing personalized immune checkpoint therapy by immune archetyping and pharmacological targeting
- Claudia Cerella
- Mario Dicato
- Marc Diederich
Pharmacological Research (2023) 196: 106914.
- Nicolas Boisgerault
- Philippe Bertrand
European Journal of Medicinal Chemistry (2023) 256: 115465.
- Chunlei Liu
- Ge Guo
- Xin Li
- Yanying Shen
- Xiang Xu
- Yibing Chen
- Hanlu Li
- Jianxiu Hao
- Kunlun He
Frontiers in Physiology (2023) 14
- Xinfang Yu
- Wei Li
- Haidan Liu
- Xu Wang
- Cristian Coarfa
- Chao Cheng
- Xinlian Yu
- Zhaoyang Zeng
- Ya Cao
- Ken H. Young
- Yong Li
Journal of Clinical Investigation (2023) 133 (3)
- Hong Liu
- Jiarui Ou
- Mien-Chie Hung
- Xiang Chen
Science Bulletin (2023) 68 (4): 356.
- Teng Zhang
- Li Yu-Jing
- Tao Ma
Frontiers in Immunology (2023) 14
- Yazhen Wang
- Yang Zhou
- Lianyi Yang
- Lei Lei
- Bin He
- Jun Cao
- Huile Gao
Advanced Science (2023)
- Liguang Fang
- Kunjing Liu
- Cun Liu
- Xiaomin Wang
- Wenzhe Ma
- Wenhua Xu
- Jibiao Wu
- Changgang Sun
Frontiers in Immunology (2022) 13
- Zhuandi Liu
- Xibao Yu
- Ling Xu
- Yangqiu Li
- Chengwu Zeng
Experimental Hematology & Oncology (2022) 11 (1)
